🇺🇸 FDA
Patent

US 12332245

Cancer biomarkers and methods of use thereof

granted A61PA61P35/00

Quick answer

US patent 12332245 (Cancer biomarkers and methods of use thereof) held by The Regents of the University of California expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jun 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61P, A61P35/00